VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 397 filers reported holding VANECK VECTORS ETF TR in Q2 2018. The put-call ratio across all filers is 0.91 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,504,000 | -51.3% | 85,509 | -55.6% | 0.24% | -39.4% |
| Q3 2019 | $5,141,000 | -51.8% | 192,465 | -59.5% | 0.40% | -33.6% |
| Q1 2019 | $10,663,000 | -25.3% | 475,595 | -38.3% | 0.60% | -30.9% |
| Q3 2018 | $14,267,000 | +3644.6% | 770,355 | +4405.8% | 0.87% | +5041.2% |
| Q2 2018 | $381,000 | -74.3% | 17,097 | -74.7% | 0.02% | -78.8% |
| Q1 2018 | $1,484,000 | -26.5% | 67,507 | -22.3% | 0.08% | -25.2% |
| Q4 2017 | $2,020,000 | -96.8% | 86,917 | -96.8% | 0.11% | -96.6% |
| Q3 2017 | $63,277,000 | +184.0% | 2,755,966 | +173.1% | 3.13% | +1.5% |
| Q2 2017 | $22,282,000 | -7.8% | 1,009,143 | -4.8% | 3.09% | +23.8% |
| Q1 2017 | $24,176,000 | +85.4% | 1,059,873 | +70.0% | 2.50% | +79.8% |
| Q4 2016 | $13,040,000 | +497.3% | 623,312 | +654.7% | 1.39% | +270.1% |
| Q3 2016 | $2,183,000 | – | 82,593 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |